Calcium Phosphate Cements Combined with Blood as a Promising Tool for the Treatment of Bone Marrow Lesions
Source abstract
Abstract
The solid phase of a commercial calcium phosphate (Graftys® HBS) was combined with ovine or human blood stabilized either with sodium citrate or sodium heparin. The presence of blood delayed the setting reaction of the cement by ca. 7–15 h, depending on the nature of the blood and blood stabilizer. This phenomenon was found to be directly related to the particle size of the HBS solid phase, since prolonged grinding of the latter resulted in a shortened setting time (10–30 min). Even though ca. 10 h were necessary for the HBS blood composite to harden, its cohesion right after injection was improved when compared to the HBS reference as well as its injectability. A fibrin-based material was gradually formed in the HBS blood composite to end-up, after ca. 100 h, with a dense 3D organic network present in the intergranular space, thus affecting the microstructure of the composite. Indeed, SEM analyses of polished cross-sections showed areas of low mineral density (over 10–20 µm) spread in the whole volume of the HBS blood composite. Most importantly, when the two cement formulations were injected in the tibial subchondral cancellous bone in a bone marrow lesion ovine model, quantitative SEM analyses showed a highly significant difference between the HBS reference versus its analogue combined with blood. After a 4-month implantation, histological analyses clearly showed that the HBS blood composite underwent high resorption (remaining cement: ca. 13.1 ± 7.3%) and new bone formation (newly formed bone: 41.8 ± 14.7%). This was in sharp contrast with the case of the HBS reference for which a low resorption rate was observed (remaining cement: 79.0 ± 6.9%; newly formed bone: 8.6 ± 4.8%). This study suggested that the particular microstructure, induced by the use of blood as the HBS liquid phase, favored quicker colonization of the implant and acceleration of its replacement by newly formed bone. For this reason, the HBS blood composite might be worth considering as a potentially suitable material for subchondroplasty.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone and Joint Diseases · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS, CEISAM, UMR 6230, Nantes Université, 44000 Nantes, France
Graftys SA, Eiffel Park, Pôle d’activités d’Aix en Provence, 13080 Aix en Provence, France
Department of Small Animal and Equine Surgery and Anesthesia, Nantes-Atlantic College of Veterinary Medicine, Food Science and Engineering (ONIRIS), 44307 Nantes, France
Regenerative Medicine and Skeleton, INSERM, University Hospital (CHU), UMR 1229-RMeS, Nantes University, 44000 Nantes, France
LCPME, CNRS UMR 7564, Université de Lorraine, 54800 Villers Lès Nancy, France
References (40)
Show source-provided references
1. A New Calcium Phosphate Setting Cement
2. Apatitic Calcium Phosphates: Possible Restorative Materials
3. Calcium phosphate Cements: Study of the β-Tricalcium Phosphate—Monocalcium Phosphate System10.1016/0142-9612(89)90089-6 ↗
4. The Use of Calcium Phosphate Bone Cement in Fracture Treatment. A Meta-Analysis of Randomized Trials10.2106/JBJS.G.00241 ↗
5. Premixed Rapid-Setting Calcium Phosphate Composites for Bone Repair10.1016/j.biomaterials.2005.01.015 ↗
6. Use of Injectable Calcium Phosphate Cement for Fracture Fixation: A Review10.1097/00003086-200202000-00004 ↗
7. Injectable Bone-Graft Substitutes: Current Products, Their Characteristics and Indications, and New Developments10.1016/j.injury.2011.06.013 ↗
8. Novel Injectable Calcium Phosphate/Chitosan Composites for Bone Substitute Materials10.1016/j.actbio.2006.03.007 ↗
9. Calcium Phosphate Cements for Bone Substitution: Chemistry, Handling and Mechanical Properties10.1016/j.actbio.2013.11.001 ↗
10. The Effect of Hyaluronic Acid on Brushite Cement Cohesion10.1016/j.actbio.2009.04.001 ↗
11. Bulk Physicochemical, Interconnectivity, and Mechanical Properties of Calcium Phosphate Cements-Fibrin Glue Composites for Bone Substitute Applications
12. Properties of Osteoconductive Biomaterials: Calcium Phosphate Cement with Different Ratios of Platelet-Rich Plasma as Identifiers10.1016/j.msec.2013.04.042 ↗
13. A Straightforward Approach to Enhance the Textural, Mechanical and Biological Properties of Injectable Calcium Phosphate Apatitic Cements (CPCs): CPC/Blood Composites, a Comprehensive Study10.1016/j.actbio.2017.08.040 ↗
14. Bujoli, B., Scimeca, J.-C., and Verron, E. (2019). Fibrin as a Multipurpose Physiological Platform for Bone Tissue Engineering and Targeted Delivery of Bioactive Compounds. Pharmaceutics, 11.10.3390/pharmaceutics11110556 ↗
15. Injection of Calcium Phosphate Apatitic Cement/Blood Composites in Intervertebral Fusion Cages: A Simple and Efficient Alternative to Autograft Leading to Enhanced Spine Fusion10.1097/BRS.0000000000003598 ↗
16. (2023, February 23). Key Features of Dragonfly. Available online: https://www.Theobjects.Com/Dragonfly/Features.html.
17. In Vivo Bone Augmentation in an Osteoporotic Environment Using Bisphosphonate-Loaded Calcium Deficient Apatite10.1016/j.biomaterials.2010.06.047 ↗
18. (2021). Standard Test Method for Time of Setting of Hydraulic-Cement Paste by Gillmore Needles (Standard No. ASTM Standard C266-20).
19. Osteotransductive Bone Cements10.1243/0954411981534196 ↗
20. High-Frequency Impedance Measurement as a Relevant Tool for Monitoring the Apatitic Cement Setting Reaction10.1016/j.actbio.2013.10.019 ↗
21. Transient Osteoporosis: Transient Bone Marrow Edema?10.1148/radiology.167.3.3363136 ↗
22. Association between Bone Marrow Lesions & Synovitis and Symptoms in Symptomatic Knee Osteoarthritis10.1016/j.joca.2019.12.002 ↗
23. Bone Marrow Lesions in Knee Osteoarthritis Change in 6–12 Weeks10.1016/j.joca.2012.08.020 ↗
24. Validation of a New Topographic Classification of Bone Marrow Lesions in the Knee: The Six-Letter System10.1007/s00167-020-05957-y ↗
25. Bone Marrow Lesion: Image, Clinical Presentation, and Treatment10.1177/1178623X17703382 ↗
26. Bone Marrow Lesions in Osteoarthritis: What Lies beneath10.1002/jor.23844 ↗
27. Long-Term Results after Microfracture Treatment for Full-Thickness Knee Chondral Lesions in Athletes10.1007/s00167-013-2676-8 ↗
28. Effect of Ibandronate on Spontaneous Osteonecrosis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Trial10.1007/s00198-013-2581-5 ↗
29. Short-Term Outcome of Painful Bone Marrow Oedema of the Knee Following Oral Treatment with Iloprost or Tramadol: Results of an Exploratory Phase II Study of 41 Patients10.1093/rheumatology/kem172 ↗
30. Subchondroplasty for Treating Bone Marrow Lesions10.1055/s-0035-1568988 ↗
31. Treating Severe Knee Osteoarthritis with Combination of Intra-Osseous and Intra-Articular Infiltrations of Platelet-Rich Plasma: An Observational Study10.1177/1947603518756462 ↗
32. Calcium Phosphate Injection of Symptomatic Bone Marrow Lesions of the Knee: What Is the Current Clinical Evidence?10.1186/s43019-019-0013-3 ↗
33. Evaluation and Management of Subchondral Calcium Phosphate Injection Technique to Treat Bone Marrow Lesion10.1177/1947603518770249 ↗
34. Hitting the Mark: Optimizing the Use of Calcium Phosphate Injections for the Treatment of Bone Marrow Lesions of the Proximal Tibia and Distal Femur10.1016/j.eats.2018.06.006 ↗
35. Subchondral Bone or Intra-Articular Injection of Bone Marrow Concentrate Mesenchymal Stem Cells in Bilateral Knee Osteoarthritis: What Better Postpone Knee Arthroplasty at Fifteen Years? A Randomized Study10.1007/s00264-020-04687-7 ↗
36. Treatment of Symptomatic Para-Articular Intraosseous Cysts by Percutaneous Injection of Bone Cement10.1007/s00256-012-1392-7 ↗
37. Surgical Treatment of Bone Marrow Lesion Associated with Recurrent Plantar Fasciitis: A Case Report Describing an Innovative Technique Using Subchondroplasty10.1053/j.jfas.2017.11.012 ↗
38. Treatment of Bone Marrow Lesions (Bone Marrow Edema)10.1038/bonekey.2015.124 ↗
39. Fokter, S.K., Kuhta, M., Hojnik, M., Ledinek, Ž., and Kostanjšek, R. (2023). Tissue Integration of Calcium Phosphate Compound after Subchondroplasty: 4-Year Follow-Up in a 76-Year-Old Female Patient. Bioengineering, 10.10.3390/bioengineering10020208 ↗
40. Tissue Reactions to Particles of Bone-Substitute Materials in Intraosseous and Heterotopic Sites in Rats: Discrimination of Osteoinduction, Osteocompatibility, and Inflammation10.1016/S0736-0266(00)00080-2 ↗